Incretin based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle
Paediatrics
Incretin based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle
Paediatrics

Incretin based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle

Clin Mol Hepatol. 2024 Jul 23. doi: 10.3350/cmh.2024.0558. Online ahead of print.

NO ABSTRACT

PMID:39038961 | DOI:10.3350/cmh.2024.0558